BlackRock's position in Thermo Fisher Scientific is currently worth $14.7B. That's 0.22% of their equity portfolio (69th largest holding). The investor owns 8.01% of the outstanding Thermo Fisher Scientific stock. The first Thermo Fisher Scientific trade was made in Q4 2020. Since then BlackRock bought shares eleven more times and sold shares on six occasions. The stake costed the investor $14.6B, netting the investor a gain of 0.4% so far.
Nanotech stocks remain at the forefront of every tech-savvy investor's portfolio, considering the predicted worldwide nanotechnology market size in 2024 is $...
Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "Medical Refrigerators - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's of...
Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the...
Strength in Analytical Instrument and Laboratory Products and Services segments is likely to have driven Thermo Fisher's (TMO) second-quarter 2024 performance.